2010
DOI: 10.1089/scd.2009.0179
|View full text |Cite
|
Sign up to set email alerts
|

Clonal Differentiation of Skeletal Muscle–Derived CD34/45 Stem Cells Into Cardiomyocytes In Vivo

Abstract: The differentiation and/or therapeutic potential of skeletal muscle-derived stem cells for cardiac infarction have been studied extensively for use in cellular cardiomyoplasty, as injured cardiomyocytes exhibit limited regenerative capacity. We previously reported cardio-myogenic differentiation of skeletal muscle-derived CD34+/45(-) (Sk-34) stem cells after therapeutic transplantation. However, the clonal differentiation potential of these cells remains unknown. Here, we show that skeletal muscle-derived CD34… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
16
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 23 publications
3
16
0
Order By: Relevance
“…Unfortunately, until now, most studies have not shown that unexpected lineage differentiation is derived from the same single cell that differentiates into the expected cell type, and even when this has been achieved, the apparent lineage switch seen to occur in general at a low frequency. Recently, some studies have shown clonal multipotency of stem cells, including MDSCs, thereby ruling out cell fusion (Tamaki et al 2007b(Tamaki et al , 2010. Thus, we believe that stem cell plasticity involves rare cells but is a real phenomenon, and not a rare event (Jang and Sharkis 2005).…”
Section: Differentiation Of Mdscsmentioning
confidence: 91%
See 1 more Smart Citation
“…Unfortunately, until now, most studies have not shown that unexpected lineage differentiation is derived from the same single cell that differentiates into the expected cell type, and even when this has been achieved, the apparent lineage switch seen to occur in general at a low frequency. Recently, some studies have shown clonal multipotency of stem cells, including MDSCs, thereby ruling out cell fusion (Tamaki et al 2007b(Tamaki et al , 2010. Thus, we believe that stem cell plasticity involves rare cells but is a real phenomenon, and not a rare event (Jang and Sharkis 2005).…”
Section: Differentiation Of Mdscsmentioning
confidence: 91%
“…In addition, Tamaki et al (2008) have reported that freshly isolated skeletal-muscle-derived CD34+/45-cells can give rise to cardiomyocytes having desmosomes and intercalated discs associated with gapjunctions after transplantation into the MI zone, significantly contributing to functional recovery of the left ventricle. Further, they have performed clonal differentiation of skeletal muscle-derived CD34-/45-stem cells into cardiomyocytes in vivo (Tamaki et al 2010). Similarly, in patients with previous myocardial infarction, treatment with MDSCs in conjunction with coronary artery bypass has been shown to be safe and feasible and is associated with increased global and regional left ventricular function, improvement in the viability of cardiac tissue in the infarct area, and no induction of arrhythmias (Herreros et al 2003).…”
Section: Cardiac Musclementioning
confidence: 99%
“…In contrast, when Sk-34 and Sk-DN cells are transplanted into a damaged cardiac muscle environment, they can give rise to cardiomyocytes having desmosomes and intercalated discs associated with gap-junctions that significantly contribute to functional recovery of the left ventricle [47]. This cardiomyogenic differentiation capacity was also confirmed to be clonal by cell transplantation and RT-PCR analysis of single cells and single cell-derived clonal cells [63].…”
Section: Myogenic Potential Of Sk-34 and Sk-dn In Vivomentioning
confidence: 95%
“…Details of the single and/or bulk-cell RT-PCR methods have been described previously (Tamaki et al 2008(Tamaki et al , 2010b. Specific primers used for the single-and bulk-cell RT-PCR are summarized in Tables 1 and 2.…”
Section: Single-and Bulk-cell Rt-pcrmentioning
confidence: 99%